Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum

doi:10.1053/j.gastro.2020.04.039

Editorial

. 2020 Aug;159(2):422-427.e1.

doi: 10.1053/j.gastro.2020.04.039. Epub 2020 Apr 27.

Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum

Collaborators, Affiliations

Collaborators

Liver Forum NASH Cirrhosis Working Group:
Frank A Anania, Jasmohan Bajaj, Katherine Barradas, Annalisa Berzigotti, Pascal Birman, Jaime Bosch, Ashley Brower, Dania Calboli, Naga Chalasani, Jean L Chan, William Charlton, Klara Dickinson, Lara Dimick-Santos, Claudia Filozof, Mikael F Forsgren, Michael Fuchs, Guadalupe Garcia-Tsao, Juan Gonzalez-Abraldes, Hans-Juergen Gruss, Morten Hansen, Suneil Hosman, Joanne Imperial, David Jones, Gadi Lalazar, Olof Dahlqvist Leinhard, Erica Lyons, Brian McColgan, Ruby Mehta, Peter Mesenbrink, Veronica Miller, Rob Myers, Mazen Noureddin, Stephanie O Omokaro, Veronica Pei, Vlad Ratziu, Arie Regev, Robert Riccio, Arun Sanyal, Elmer Schabel, Suna Seo, Alastair Smith, Peter Szitanyi, Peter Traber

Affiliations

¹ Cedars Sinai Medical Center, Los Angeles, California.
² Conatus Pharmaceuticals, San Diego, California.
³ University of California, Berkeley, California.
⁴ US Food and Drug Administration, Silver Spring, Maryland.
⁵ Bundesinstitut fuer Arzneimittel und Medizinprodukte, Bonn, Germany.
⁶ Gilead Sciences, Inc., Foster City, California.
⁷ Virginia Commonwealth University, Richmond, Virginia.
⁸ Indiana University School of Medicine, Indianapolis, Indiana.

PMID: 32353369
DOI: 10.1053/j.gastro.2020.04.039

Editorial

Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum

Mazen Noureddin et al. Gastroenterology. 2020 Aug.

. 2020 Aug;159(2):422-427.e1.

doi: 10.1053/j.gastro.2020.04.039. Epub 2020 Apr 27.

Collaborators

Liver Forum NASH Cirrhosis Working Group:
Frank A Anania, Jasmohan Bajaj, Katherine Barradas, Annalisa Berzigotti, Pascal Birman, Jaime Bosch, Ashley Brower, Dania Calboli, Naga Chalasani, Jean L Chan, William Charlton, Klara Dickinson, Lara Dimick-Santos, Claudia Filozof, Mikael F Forsgren, Michael Fuchs, Guadalupe Garcia-Tsao, Juan Gonzalez-Abraldes, Hans-Juergen Gruss, Morten Hansen, Suneil Hosman, Joanne Imperial, David Jones, Gadi Lalazar, Olof Dahlqvist Leinhard, Erica Lyons, Brian McColgan, Ruby Mehta, Peter Mesenbrink, Veronica Miller, Rob Myers, Mazen Noureddin, Stephanie O Omokaro, Veronica Pei, Vlad Ratziu, Arie Regev, Robert Riccio, Arun Sanyal, Elmer Schabel, Suna Seo, Alastair Smith, Peter Szitanyi, Peter Traber

Affiliations

¹ Cedars Sinai Medical Center, Los Angeles, California.
² Conatus Pharmaceuticals, San Diego, California.
³ University of California, Berkeley, California.
⁴ US Food and Drug Administration, Silver Spring, Maryland.
⁵ Bundesinstitut fuer Arzneimittel und Medizinprodukte, Bonn, Germany.
⁶ Gilead Sciences, Inc., Foster City, California.
⁷ Virginia Commonwealth University, Richmond, Virginia.
⁸ Indiana University School of Medicine, Indianapolis, Indiana.

PMID: 32353369
DOI: 10.1053/j.gastro.2020.04.039

No abstract available

PubMed Disclaimer

Cited by

Outcomes and potential surrogate markers for future clinical trials of non-alcoholic steatohepatitis cirrhosis.
Rivera-Esteban J, Armandi A, Augustin S, Bugianesi E. Rivera-Esteban J, et al. Liver Int. 2021 Sep;41(9):1999-2008. doi: 10.1111/liv.15013. Epub 2021 Jul 21. Liver Int. 2021. PMID: 34242466 Free PMC article. Review.
Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
Mann JP, Carter P, Armstrong MJ, Abdelaziz HK, Uppal H, Patel B, Chandran S, More R, Newsome PN, Potluri R. Mann JP, et al. PLoS One. 2020 Oct 27;15(10):e0241357. doi: 10.1371/journal.pone.0241357. eCollection 2020. PLoS One. 2020. PMID: 33108366 Free PMC article.
Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis.
Noureddin M, Goodman Z, Tai D, Chng ELK, Ren Y, Boudes P, Shlevin H, Garcia-Tsao G, Harrison SA, Chalasani NP. Noureddin M, et al. Aliment Pharmacol Ther. 2023 Feb;57(4):409-417. doi: 10.1111/apt.17363. Epub 2023 Jan 17. Aliment Pharmacol Ther. 2023. PMID: 36647687 Free PMC article.
Magnetic Resonance Elastography as a Predictor of Response to Therapy in Patients With Nonalcoholic Steatohepatitis.
Noureddin M. Noureddin M. Gastroenterol Hepatol (N Y). 2021 Oct;17(10):488-490. Gastroenterol Hepatol (N Y). 2021. PMID: 35462729 Free PMC article. No abstract available.
Global epidemiology of cirrhosis - aetiology, trends and predictions.
Huang DQ, Terrault NA, Tacke F, Gluud LL, Arrese M, Bugianesi E, Loomba R. Huang DQ, et al. Nat Rev Gastroenterol Hepatol. 2023 Jun;20(6):388-398. doi: 10.1038/s41575-023-00759-2. Epub 2023 Mar 28. Nat Rev Gastroenterol Hepatol. 2023. PMID: 36977794 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum

Collaborators

Affiliations

Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum

Authors

Collaborators

Affiliations

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical